ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)

Alcon Research300 enrolled

Overview

Randomized, parallel group, subject masked, multi-center six (6) month follow-up study comparing ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power IOL Model SN6AD1 implanted in both eyes to ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power IOL Model SN6AD3 implanted in both eyes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

300

Conditions

Cataract

Interventions

ACRYSOF® ReSTOR® Aspheric +4.0 D Add Power Intraocular LensDEVICE

Intraocular Lens

ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular LensDEVICE

Intraocular Lens

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion: * Adults, 21 years of age or older at the time of surgery, of either gender or any race, diagnosed with bilateral cataracts * Calculated lens power is within the available range * Willing and able to complete all required postoperative visits * Planned cataract removal by phacoemulsification and/or liquifacture * Potential postoperative visual acuity of 0.2 logMAR or better in study eyes * Preoperative astigmatism of 1.0 Diopter (D) or less, measured by keratometry in study eyes * Clear intraocular media other than cataract in study eyes * Able to comprehend and sign a statement of informed consent * Preoperative Best Corrected Distance Visual Acuity (BCDVA) worse than 0.2 logMAR, or if BCDVA is equal to or better than 0.2 logMAR, BCDVA with a Brightness Acuity Tester (BAT) on "Medium" setting must be worse than 0.2 logMAR Exclusion: * Significant irregular corneal aberration as demonstrated by corneal topography * Subjects with diagnosed degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.2 logMAR * Subjects who may reasonably be expected to require laser treatments at any time * Previous corneal refractive surgery * Amblyopia * Clinically severe corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy) * Diabetic retinopathy * Extremely shallow anterior chamber, not due to swollen cataract * Microphthalmos * Previous retinal detachment * Previous corneal transplant * Recurrent severe anterior or posterior segment inflammation of unknown etiology * Rubella or traumatic cataract * Iris neovascularization * Glaucoma (uncontrolled or controlled with medication) * Aniridia * Optic nerve atrophy * Pregnancy * Current or previous usage of an alpha-1-selective adrenoceptor blocking agent or an antagonist of alpha 1A adrenoceptor (e.g.Flomax® (tamsulosin HCL), Hytrin®, or Cardura®) * Any subject currently participating in another investigational drug or device study that may confound the results of this investigation

Locations (1)

Call Center for Locations

Fort Worth, Texas, United States

Outcomes

Primary Outcomes

Binocular Distance Corrected Near Visual Acuity at Best Distance (That Which Provides the Subject With the Best Vision)

Binocular Distance Corrected Near Visual Acuity at Best Distance (that which provides the subject with the best vision)measured in mean logMAR. logMAR is the logarithm of the minimum angle of resolution, which is a measure for visual acuity (VA). Mean logMAR is the average value of visual acuity.

Time frame: 3 months

Secondary Outcomes

Binocular Distance Corrected Distance Visual Acuity

Binocular Distance Corrected Distance Visual Acuity measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution, which is a measure for visual acuity (VA).

Time frame: 3 months post-operative

Binocular Distance Corrected Intermediate Visual Acuity (Tested at 50 cm)

Binocular Distance Corrected Intermediate Visual Acuity (tested at 50 cm) measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution, which is a measure for visual acuity (VA).

Time frame: 3 months post-operative

Binocular Distance Corrected Intermediate Visual Acuity (Tested at 60 cm)

Binocular Distance Corrected Intermediate Visual Acuity (tested at 60 cm)measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution, which is a measure for visual acuity (VA).

Time frame: 3 months post-operative

Binocular Distance Corrected Intermediate Visual Acuity (Tested at 70 cm)

Binocular Distance Corrected Intermediate Visual Acuity (tested at 70 cm) measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution, which is a measure for visual acuity (VA).

Time frame: 3 months post-operative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.